Novartis
NVS
$81.96
Share price
-2.04%
Change (1 day)
-4.60%
Change (1 year)
Categories
Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
Number of shares outstanding for Novartis (NVS)
Number of shares outstanding as of March 2023 : 2,167,000,000
According to Novartis's latest financial reports and stock price the company's current number of shares outstanding is 2,167,000,000. At the end of 2022 the company had 2,167,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Novartis from 2001 to 2022
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2022 | 2.16 B | -3.13% |
| 2021 | 2.23 B | -1.24% |
| 2020 | 2.26 B | |
| 2019 | 2.26 B | 9.19% |
| 2018 | 2.07 B | -0.3% |
| 2017 | 2.08 B | -2.23% |
| 2016 | 2.12 B | -0.42% |
| 2015 | 2.13 B | -0.96% |
| 2014 | 2.15 B | -0.99% |
| 2013 | 2.17 B | 0.5% |
| 2012 | 2.16 B | -0.17% |
| 2011 | 2.17 B | 5.94% |
| 2010 | 2.05 B | 0.88% |
| 2009 | 2.03 B | 0.18% |
| 2008 | 2.02 B | -2.07% |
| 2007 | 2.07 B | -1.51% |
| 2006 | 2.10 B | 0.15% |
| 2005 | 2.10 B | -3.96% |
| 2004 | 2.18 B | -1.51% |
| 2003 | 2.22 B | -1.98% |
| 2002 | 2.26 B | -1.14% |
| 2001 | 2.29 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,627,900,000 | 21.27% | 🇺🇸 USA |
 Pfizer PFE | 5,607,000,000 | 158.74% | 🇺🇸 USA |
 Abbott Laboratories ABT | 1,737,795,021 | -19.81% | 🇺🇸 USA |
 Sanofi SNY | 2,507,000,000 | 15.69% | 🇫🇷 France |
 Merck MRK | 2,533,000,000 | 16.89% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,133,000,000 | -1.57% | 🇺🇸 USA |
 AstraZeneca AZN | 3,096,000,000 | 42.87% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2,017,000,000 | -6.92% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 1,111,000,000 | -48.73% | 🇮🇱 Israel |